相关实验视频

Updated: Jan 7, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

在描述LI-RADS 3观察中PSMA PET/MRI的诊断性能肝硬化患者的观察

Onofrio Antonio Catalano¹, Irun Bhan², Luigi Asmundo³

¹Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; onofriocatalano@yahoo.it.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

|December 30, 2025

概括

前列腺特异性膜抗原 (PSMA) PET/MRI显著改善了肝硬化患者不确定的肝损伤 (LR-3) 的表征. 这种先进的成像技术提供了高精度,可能减少了对后续扫描和活检的需求.

科学领域:

肝胆道成像检查肝胆道成像检查
瘤成像 - - 癌症成像
核医学是一种核医学.

背景情况:

肝脏成像报告和数据系统 (LI-RADS) 3类 (LR-3) 在肝硬化患者中的观察是不确定的,通常需要进一步调查.
肝细胞癌 (HCC) 在其新血管结构中过度表达前列腺特异性膜抗原 (PSMA),表明其作为成像生物标志物的潜力.

研究的目的:

为了评估[68Ga]Ga-PSMA-11 PET/MRI在对肝硬化患者的LR-3肝脏观察进行特征化的有效性.
为了比较[68Ga]Ga-PSMA-11 PET/MRI 对这些不确定的病变的诊断性能与单独的MRI.

主要方法:

一项前性研究,涉及19名肝硬化患者和54名LR-3观察者在先前的MRI上.
所有患者都接受了[68Ga]Ga-PSMA-11 PET/MRI.
HCC是由焦点[68Ga]Ga-PSMA吸收>肝脏背景加上LI-RADS主要/辅助特征定义的;参考标准是组织病理学或12个月后续MRI.

主要成果:

[68Ga]Ga-PSMA-11 PET/MRI实现了92%的灵敏度和95%的HCC检测特异性.
整体诊断准确率为94%,正预测值为86%,负预测值为97%.
诊断性能明显优于单独的MRI (P < 0.001),[68Ga]Ga-PSMA-11吸收是恶性瘤的关键预测因素.

结论:

[68Ga]Ga-PSMA-11 PET/MRI在肝硬化患者的恶性与良性LR-3肝脏观察区分方面表现出高准确性.
这种成像模式在减少不必要的后续成像和侵入性活检方面表现有前途.
建议对[68Ga]Ga-PSMA-11 PET/MRI进行进一步的验证,因为它是不确定的肝损伤的宝贵工具.

关键词:

李-RADS 3 三个轮子 [68Ga]Ga-PSMA-11 皮肤核磁共振成像肝细胞癌是肝细胞癌.肝硬化是肝硬化的一种疾病.分子成像分子成像技术

更多相关视频

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Published on: December 30, 2016

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

相关概念视频

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...